BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22270865)

  • 1. Angiogenesis and survival in patients with myelodysplastic syndrome.
    Savic A; Cemerikic-Martinovic V; Dovat S; Rajic N; Urosevic I; Sekulic B; Kvrgic V; Popovic S
    Pathol Oncol Res; 2012 Jul; 18(3):681-90. PubMed ID: 22270865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents.
    Kim CK; Han DH; Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Lee KT; Won JH; Hong DS; Kim HK
    Leuk Res; 2016 Nov; 50():21-28. PubMed ID: 27639703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
    Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
    Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
    Zou WR; Liu T; Meng WT; Yu J; Niu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes.
    Cheng CL; Hou HA; Jhuang JY; Lin CW; Chen CY; Tang JL; Chou WC; Tseng MH; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Br J Cancer; 2011 Sep; 105(7):975-82. PubMed ID: 21878936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor.
    Steurer M; Zoller H; Augustin F; Fong D; Heiss S; Strasser-Weippl K; Gastl G; Tzankov A
    Hum Pathol; 2007 Jul; 38(7):1057-1064. PubMed ID: 17442379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
    Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
    Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic evaluation of the microvascular network in myelodysplastic syndromes.
    Korkolopoulou P; Apostolidou E; Pavlopoulos PM; Kavantzas N; Vyniou N; Thymara I; Terpos E; Patsouris E; Yataganas X; Davaris P
    Leukemia; 2001 Sep; 15(9):1369-76. PubMed ID: 11516097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of clinical prognostic value of vascular endothelial growth factor and microvessel density in multiple myeloma.
    Choi JH; Ahn MJ; Jang SJ; Park CK; Park YW; Oh HS; Lee YY; Choi IY; Kim IS
    Int J Hematol; 2002 Dec; 76(5):460-4. PubMed ID: 12512841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
    Keith T; Araki Y; Ohyagi M; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Kitagawa M
    Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDF-1/CXCR4 axis in myelodysplastic syndromes: correlation with angiogenesis and apoptosis.
    Zhang Y; Zhao H; Zhao D; Sun L; Zhi Y; Wu X; Huang W; Da W
    Leuk Res; 2012 Mar; 36(3):281-6. PubMed ID: 21802140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia.
    Fu J; Fu J; Chen X; Zhang Y; Gu H; Bai Y
    Jpn J Clin Oncol; 2010 Nov; 40(11):1046-52. PubMed ID: 20558462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia.
    Patsouris E; Korkolopoulou P; Androulaki A; Douzinas E; Kosmopoulou O; Kordossis T
    Pathology; 2003 Aug; 35(4):330-5. PubMed ID: 12959769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome.
    Verstovsek S; Estey E; Manshouri T; Giles FJ; Cortes J; Beran M; Rogers A; Keating M; Kantarjian H; Albitar M
    Br J Haematol; 2002 Jul; 118(1):151-6. PubMed ID: 12100142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in myelodysplastic syndromes.
    Pruneri G; Bertolini F; Soligo D; Carboni N; Cortelezzi A; Ferrucci PF; Buffa R; Lambertenghi-Deliliers G; Pezzella F
    Br J Cancer; 1999 Dec; 81(8):1398-401. PubMed ID: 10604739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the proliferation-associated nuclear protein MIB-1 and its relationship with microvascular density in bone marrow biopsies of patients with myelodysplastic syndromes.
    Alexandrakis MG; Passam FH; Kyriakou DS; Dambaki C; Katrinakis G; Tsirakis G; Konsolas J; Stathopoulos EN
    J Mol Histol; 2004 Nov; 35(8-9):857-63. PubMed ID: 15609099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
    Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
    Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of patients with myeloproliferative disorders (MPD).
    Wróbel T; Mazur G; Surowiak P; Wolowiec D; Jelen M; Kuliczkowsky K
    Pathol Oncol Res; 2003; 9(3):170-3. PubMed ID: 14530810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.